Lowest-Rated StocksLowest-RatedNASDAQ:SILK Silk Road Medical (SILK) Stock Price, News & Analysis $27.02 +0.01 (+0.04%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$26.97▼$27.0550-Day Range$20.58▼$27.0952-Week Range$6.08▼$27.19Volume1.08 million shsAverage Volume1.16 million shsMarket Capitalization$1.07 billionP/E RatioN/ADividend YieldN/APrice Target$21.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Silk Road Medical alerts: Email Address Silk Road Medical MarketRank™ Stock AnalysisAnalyst RatingReduce1.90 Rating ScoreUpside/Downside20.4% Downside$21.50 Price TargetShort InterestBearish5.30% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.83Based on 5 Articles This WeekInsider TradingSelling Shares$1,782 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.43) to ($1.34) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.93 out of 5 starsMedical Sector426th out of 936 stocksSurgical & Medical Instruments Industry55th out of 101 stocks 2.0 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on 1 buy rating, 7 hold ratings, and 2 sell ratings.Amount of Analyst CoverageSilk Road Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Silk Road Medical's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.30% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Silk Road Medical has recently increased by 0.48%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 3.2 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Silk Road Medical this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for SILK on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,782.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of Silk Road Medical is held by insiders.Read more about Silk Road Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.43) to ($1.34) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -19.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -19.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 6.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Silk Road Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Silk Road Medical Stock (NASDAQ:SILK)Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Stock News HeadlinesJuly 24 at 6:30 AM | prnewswire.comBoston Scientific Announces Results for Second Quarter 2024July 21, 2024 | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Recommendation of "Reduce" from AnalystsJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 19, 2024 | benzinga.comA Closer Look at 4 Analyst Recommendations For Silk Road MedicalJuly 19, 2024 | msn.comStifel Downgrades Silk Road Medical (SILK)July 18, 2024 | americanbankingnews.comStifel Nicolaus Reaffirms Hold Rating for Silk Road Medical (NASDAQ:SILK)July 16, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. – SILKJuly 15, 2024 | prnewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. - SILKJuly 26, 2024 | WealthPress (Ad)New trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.June 24, 2024 | globenewswire.comSILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston ScientificJune 19, 2024 | businesswire.comSILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILKJune 18, 2024 | prnewswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.June 18, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Silk Road Medical, Inc. has obtained a Fair Price for its Public ShareholdersJune 18, 2024 | investorplace.comWhy Is Silk Road Medical (SILK) Stock Up 24% Today?June 18, 2024 | globenewswire.comBreaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal TermsJune 18, 2024 | businesswire.comSILK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Silk Road Medical, Inc. Is Fair to ShareholdersJune 18, 2024 | barrons.comSilk Road Medical Stock Soars. It's Being Acquired by Boston Scientific.June 18, 2024 | reuters.comBoston Scientific to buy Silk Road Medical in $1.16 billion dealSee More Headlines Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today7/26/2024Next Earnings (Estimated)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees410Year FoundedN/APrice Target and Rating Average Stock Price Target$21.50 High Stock Price Target$30.00 Low Stock Price Target$8.00 Potential Upside/Downside-20.3%Consensus RatingReduce Rating Score (0-4)1.90 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($1.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,740,000.00 Net Margins-29.02% Pretax Margin-28.80% Return on Equity-35.47% Return on Assets-20.67% Debt Debt-to-Equity Ratio0.52 Current Ratio11.05 Quick Ratio9.62 Sales & Book Value Annual Sales$177.13 million Price / Sales6.01 Cash FlowN/A Price / Cash FlowN/A Book Value$3.88 per share Price / Book6.96Miscellaneous Outstanding Shares39,440,000Free Float37,906,000Market Cap$1.06 billion OptionableOptionable Beta1.52 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Lucas W. Buchanan (Age 46)CFO & COO Comp: $870.55kMr. Kevin M. Klemz (Age 63)EVP, Chief Legal Officer & Secretary Comp: $644.12kMr. Andrew S. Davis (Age 55)Chief Commercial Officer Comp: $836.33kMr. Richard M. Ruedy (Age 57)Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance Comp: $542.41kMr. Charles S. McKhann (Age 55)Chief Executive Officer Ms. Mhairi L. Jones (Age 53)Chief Accounting Officer & VP of Finance Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsMr. Jorge O'HaraVice President of Marketing, Business Development & StrategyMs. Alison HighlanderVice President of Human ResourcesDr. Sumaira MacDonald M.D.Ph.D., Executive Medical DirectorMore ExecutivesKey CompetitorsCardiovascular SystemsNASDAQ:CSIIInovio PharmaceuticalsNASDAQ:INOLeMaitre VascularNASDAQ:LMATPROCEPT BioRoboticsNASDAQ:PRCTInari MedicalNASDAQ:NARIView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 22,866 shares on 7/26/2024Ownership: 0.351%Assenagon Asset Management S.A.Sold 35,230 shares on 7/18/2024Ownership: 0.022%Andrew S DavisSold 66 sharesTotal: $1,782.00 ($27.00/share)Cetera Advisors LLCBought 38,759 shares on 5/24/2024Ownership: 0.098%Bayesian Capital Management LPBought 13,611 shares on 5/16/2024Ownership: 0.035%View All Insider TransactionsView All Institutional Transactions SILK Stock Analysis - Frequently Asked Questions How have SILK shares performed this year? Silk Road Medical's stock was trading at $12.27 on January 1st, 2024. Since then, SILK shares have increased by 120.2% and is now trading at $27.02. View the best growth stocks for 2024 here. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.04. The firm's quarterly revenue was up 20.9% compared to the same quarter last year. When did Silk Road Medical IPO? Silk Road Medical (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. Who are Silk Road Medical's major shareholders? Top institutional investors of Silk Road Medical include Bank of New York Mellon Corp (0.35%) and Assenagon Asset Management S.A. (0.02%). Insiders that own company stock include Lucas W Buchanan, Andrew S Davis, Erica J Rogers, Kevin M Klemz, Richard Ruedy, Marie L Jones and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW) and This page (NASDAQ:SILK) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silk Road Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
